InsidersTradesSigma
Follow the Hangzhou Tigermed Consulting Co., Ltd. - H Shares share price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Market capitalisation: €46.8bn. The latest transaction was reported on 19 May 2026 (Other). Among the most active insiders: Cao xiaochun. All data is openly available.
Analysts rate Hangzhou Tigermed Consulting Co., Ltd. - H Shares Buy (bullish), based on 13 analysts. Average price target: CN¥62.28.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Hangzhou Tigermed Consulting Co., Ltd. es una empresa china especializada en servicios de investigación clínica. Se centra en apoyar a las empresas farmacéuticas y biofarmacéuticas en el desarrollo de nuevos fármacos.